# European Respiratory Society

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/european-respiratory-society
Canonical HTML page: https://gethealthbrief.com/entity/european-respiratory-society

## Recent coverage (1 stories)

### Semaglutide tied to 40% fewer asthma attacks, 20% fewer COPD flare-ups
2026-09-10 18:59:37 · Sentiment: Positive · Impact: 7/10 · Sources: 2

A real-world UK EHR study presented at ERS found semaglutide associated with 40% fewer asthma attacks and 20% fewer COPD flare-ups. Health systems should treat this as an early signal that GLP-1s may have respiratory benefits, not yet a treatment recommendation.
Full story: https://gethealthbrief.com/story/glp-1-semaglutide-40-percent-fewer-asthma-attacks-copd-flare-ups-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.